Biotech drugmaker Genentech Inc. said Sunday the Food and Drug Administration approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval for the blockbuster drug.
FDA clears Genentech drug for kidney cancerCourtesy Newsvine - business Sun, 08/02/2009 - 20:02
Biotech drugmaker Genentech Inc. said Sunday the Food and Drug Administration approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval for the blockbuster drug. Related itemsFDA nixes wider use of rheumatoid arthritis drug
Diet Treatment, Already in Use, to Get F.D.A. Review
Mead Johnson Says Its Tests Show Enfamil Baby Formula...
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Popular by tags WeekMonth |
Post new comment